103
Participants
Start Date
October 16, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
February 15, 2026
MAR
Once-daily tablet
Carolina Research Center, Inc. (Noah Clinical Site 009), Shelby
Neurology Associates of Ormond Beach (Noah Clinical Site 015), Ormond Beach
Accel Research Sites (Noah Clinical Site 019), DeLand
Best Choice Medical and Research Service (Noah Clinical Site 025), Pembroke Pines
Life Well Research Center (Noah Clinical Site 008), Miami
Regenerate Primary Medical Research (Noah Clinical Site 003), Miami
Miami Jewish Health (Noah Clinical Site 023), Miami
International Medical Investigational Centers (Noah Clinical Site 001), Palmetto Bay
Health Awareness (Noah Clinical Site 020), Jupiter
Denali Health Plant City, LLC (Noah Clinical Site 024), Plant City
Tekton Research (Noah Clinical Site 002), Yukon
Olympus Clinical Research (Noah Clinical Site 014), Katy
Scottsdale Clinical Trials (Noah Clinical Site 017), Scottsdale
IMA Clinical Research (Noah Clinical Site 004), Albuquerque
Marvel Clinical Research (Noah Clinical Site 010), Huntington Beach
Boston Clinical Trials (Noah Clinical Site 006), Boston
Lead Sponsor
Noah Pharmaceuticals, Inc.
INDUSTRY